DR. Nicholas A Klaiber, MD is an allergy immunology in Fredericksburg, VA with 11 years of experience. The provider is an allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system. DR. Nicholas A Klaiber, MD NPI is 1396182275. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: EASTERN VIRGINIA MEDICAL SCHOOL
Graduation Year:2013
The provider's business location address is:
511 PARK HILL DR
FREDERICKSBURG, VA
ZIP 22401-377
Phone: (540) 371-5660
Fax: (540) 372-6920
The NPI 1396182275 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection of allergenic extracts into skin, accessed through the skin (HCPCS:95004)
- Preparation and provision of single or multiple antigens for allergen immunotherapy (HCPCS:95165)
- Injection of allergenic extracts into skin for immediate reaction analysis (HCPCS:95024)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Injection of incremental dosages of allergen, 2 or more injections (HCPCS:95117)
The enumeration date for this NPI number is 5/31/2013 and was last updated on 10/31/2023.